Da Vinci Platform Executive Sells Shares Following Stock Option Exercise Amid Small Stake Liquidation

On June 1, Intuitive Surgical (NASDAQ: ISRG) SVP & GM of da Vinci Platforms Iman Jeddi exercised non-qualified stock options to acquire company common shares and, later that same day, sold an identical number of shares at approximately $420.55 each. This transaction was executed under a pre-established Rule 10b5-1 trading plan, combining option exercise with a sale of shares as part of regular, compensation-related stock management rather than a new purchase or discretionary large-scale divestiture. Over the past few weeks, the company’s Chief Legal & Compliance Officer and the executive responsible for Manufacturing & Supply Chain have also sold small portions of their holdings under similar Rule 10b5-1 plans.

In its first-quarter 2026 earnings release, Intuitive Surgical reported revenue and earnings that beat market expectations, reaffirming the ongoing rise in procedure volumes and installations of its da Vinci robotic surgery systems. On May 21, the company unveiled new ecosystem-wide features—including the da Vinci 5 and the SimNow training and simulation platform—and announced plans for a phased U.S. rollout beginning in June.

Headquartered in Sunnyvale, California, Intuitive Surgical is a leading provider of robotic surgical systems, with its flagship da Vinci robot designed for minimally invasive surgery. The company has expanded its installed base and procedure volumes in major hospitals worldwide and has built a business model in which system sales are complemented by significant recurring revenue from surgical consumables and services.